Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
December 19, 2019 10:03 ET
|
Pressure BioSciences, Inc.
Significant Revenue Growth Reported in Consumable Products (158%) and Scientific Services (87%);Company Continues to Gain Momentum in Its PCT, BaroFold, and UST Technology Platforms Investor...
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update
December 18, 2019 08:00 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a...
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
October 04, 2019 08:04 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
October 01, 2019 07:30 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
September 26, 2019 09:29 ET
|
Pressure BioSciences, Inc.
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA,...
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer
September 17, 2019 10:33 ET
|
Pressure BioSciences, Inc.
Shea’s 30-Year Diverse Experience in Acquisitions, Capital Markets, SEC Reporting, and Leading Financial Organizations Bolsters PBI’s Strong Senior Management Team South Easton, MA, Sept. 17,...
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
September 10, 2019 09:33 ET
|
Pressure BioSciences, Inc.
Two Prestigious Research Centers Report PBI’s PCT Platform Delivers Superior Results for Protein Biomarker Discovery Studies from Preserved Cancer Biopsy Tissue Samples SOUTH EASTON, MA,...
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
August 22, 2019 09:08 ET
|
Pressure BioSciences, Inc.
Company Forecasts All 12 Systems in Current Build Cycle Will Be Sold by September 30, 2019 and Reiterates Previous Guidance for More Than Doubling of Annual Revenue in 2020 SOUTH EASTON, MA,...
Uptick Newswire Hosts Pressure BioSciences, Inc. on the Stock Day Podcast to Discuss Their (1) Just Announced Collaboration With NutraFuels, Inc., (2) the Commercial Launch of Their BioPharmaceuticals Contract Services Business, and (3) the Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018
February 04, 2019 08:13 ET
|
Pressure BioSciences, Inc.
PHOENIX, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of...
Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast
October 01, 2018 08:30 ET
|
Pressure BioSciences, Inc.
PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pressure BioSciences Inc. (OTCQB: PBIO) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments,...